ArticlePloS one2019

Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer.

Tuomas Kaprio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.